Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

NCT06192160 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

315

Enrollment

NIH

Sponsor class

Conditions

Pulmonary Tuberculosis

Interventions

DRUG: Isoniazid
DRUG: Rifampicin
DRUG: Pyrazinamide
DRUG: Ethambutol
DRUG: Bedaquiline
DRUG: Pretomanid
DRUG: Linezolid
DRUG: TBI-223
DRUG: Sutezolid
DRUG: TBI-223
DRUG: Sutezolid

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]